Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?

Ayalew Tefferi; Tiziano Barbui

doi:10.1002/ajh.27369

Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?

Am J Hematol. 2024 May 16. doi: 10.1002/ajh.27369. Online ahead of print.

Authors

Ayalew Tefferi¹, Tiziano Barbui²

Affiliations

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

PMID: 38752361
DOI: 10.1002/ajh.27369

Abstract

Asprin dosing strategy in low risk (young and JAK2 mutated without history of thrombosis) or very low risk (young JAK2 wild-type without history of thrombosis) essential thrombocythemia.

Publication types

Editorial